BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Young A, Rea D. ABC of colorectal cancer: treatment of advanced disease. BMJ. 2000;321:1278-1281. [PMID: 11082094 DOI: 10.1136/bmj.321.7271.1278] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Dinh L, Hong J, Min Kim D, Lee G, Jung Park E, Hyuk Baik S, Hwang SJ. A novel thermosensitive poloxamer-hyaluronic acid- kappa-carrageenan-based hydrogel anti-adhesive agent loaded with 5-fluorouracil: a preclinical study in Sprague-Dawley rats. Int J Pharm 2022;:121771. [PMID: 35487401 DOI: 10.1016/j.ijpharm.2022.121771] [Reference Citation Analysis]
2 Atapour A, Khajehzadeh H, Shafie M, Abbasi M, Mosleh-shirazi S, Kasaee SR, Amani AM. Gold nanoparticle-based aptasensors: A promising perspective for early-stage detection of cancer biomarkers. Materials Today Communications 2022;30:103181. [DOI: 10.1016/j.mtcomm.2022.103181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Duarte D, Vale N. Combining repurposed drugs to treat colorectal cancer. Drug Discov Today 2021:S1359-6446(21)00406-2. [PMID: 34592446 DOI: 10.1016/j.drudis.2021.09.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Musoro JZ, Sodergren SC, Coens C, Pochesci A, Terada M, King MT, Sprangers MAG, Groenvold M, Cocks K, Velikova G, Flechtner HH, Bottomley A; EORTC Quality of Life, Gastro-intestinal Groups. Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy. Colorectal Dis 2020;22:2278-87. [PMID: 32767619 DOI: 10.1111/codi.15295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ouyang S, Zhou X, Chen Z, Wang M, Zheng X, Xie M. LncRNA BCAR4, targeting to miR-665/STAT3 signaling, maintains cancer stem cells stemness and promotes tumorigenicity in colorectal cancer. Cancer Cell Int 2019;19:72. [PMID: 30962766 DOI: 10.1186/s12935-019-0784-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 43] [Article Influence: 10.7] [Reference Citation Analysis]
6 Bendardaf R, El-Serafi A, Syrjänen K, Collan Y, Pyrhönen S. The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients. Libyan J Med 2017;12:1290741. [PMID: 28245709 DOI: 10.1080/19932820.2017.1290741] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kim HY, Kim J, Ha Thi HT, Bang OS, Lee WS, Hong S. Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model. BMC Complement Altern Med 2016;16:473. [PMID: 27863496 DOI: 10.1186/s12906-016-1447-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
8 Qualtrough D, Rees P, Speight B, Williams AC, Paraskeva C. The Hedgehog Inhibitor Cyclopamine Reduces β-Catenin-Tcf Transcriptional Activity, Induces E-Cadherin Expression, and Reduces Invasion in Colorectal Cancer Cells. Cancers (Basel) 2015;7:1885-99. [PMID: 26393651 DOI: 10.3390/cancers7030867] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sokolov M, Angelov K, Vasileva M, Atanasova MP, Vlahova A, Todorov G. Clinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancer. Onco Targets Ther 2015;8:2329-37. [PMID: 26366089 DOI: 10.2147/OTT.S82958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Bodalal Z, Bendardaf R. Colorectal carcinoma in a Southern Mediterranean country: The Libyan scenario. World J Gastrointest Oncol 2014; 6(4): 98-103 [PMID: 24734155 DOI: 10.4251/wjgo.v6.i4.98] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
11 Petitguillaume A, Bernardini M, Hadid L, de Labriolle-Vaylet C, Franck D, Desbrée A. Three-dimensional personalized Monte Carlo dosimetry in 90Y resin microspheres therapy of hepatic metastases: nontumoral liver and lungs radiation protection considerations and treatment planning optimization. J Nucl Med 2014;55:405-13. [PMID: 24504053 DOI: 10.2967/jnumed.113.120444] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zhong LL, Chen HY, Cho WC, Meng XM, Tong Y. The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis. Complement Ther Med. 2012;20:240-252. [PMID: 22579437 DOI: 10.1016/j.ctim.2012.02.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
13 Bouché O, Beretta GD, Alfonso PG, Geissler M. The role of anti-epidermal growth factor receptor monoclonal antibody monotherapy in the treatment of metastatic colorectal cancer. Cancer Treatment Reviews 2010;36:S1-S10. [DOI: 10.1016/s0305-7372(10)00036-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
14 Qualtrough D, Singh K, Banu N, Paraskeva C, Pignatelli M. The actin-bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro. Br J Cancer 2009;101:1124-9. [PMID: 19738613 DOI: 10.1038/sj.bjc.6605286] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
15 Krol M, Koopman M, Uyl-de Groot C, Punt CJ. A systematic review of economic analyses of pharmaceutical therapies for advanced colorectal cancer. Expert Opin Pharmacother. 2007;8:1313-1328. [PMID: 17563265 DOI: 10.1517/14656566.8.9.1313] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bendardaf R, Lamlum H, Ristamäki R, Korkeila E, Syrjänen K, Pyrhönen S. Mismatch Repair Status Is a Predictive Factor of Tumour Response to 5-Fluorouracil and Irinotecan Chemotherapy in Patients with Advanced Colorectal Cancer. Tumor Biol 2007;28:212-20. [DOI: 10.1159/000107417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
17 Ward SE, Kaltenthaler E, Cowan J, Marples M, Orr B, Seymour MT. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. Br J Cancer. 2006;95:27-34. [PMID: 16804526 DOI: 10.1038/sj.bjc.6603215] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
18 Stein KD, Denniston M, Baker F, Dent M, Hann DM, Bushhouse S, West M. Validation of a modified Rotterdam Symptom Checklist for use with cancer patients in the United States. J Pain Symptom Manage 2003;26:975-89. [PMID: 14585549 DOI: 10.1016/s0885-3924(03)00321-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
19 Twelves CJ, Cassidy J. Which endpoints should we use in evaluating the use of novel fluoropyrimidine regimens in colorectal cancer? Br J Cancer 2002;86:1670-6. [PMID: 12087448 DOI: 10.1038/sj.bjc.6600341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
20 Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D. Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 2002;86:443-8. [PMID: 11875713 DOI: 10.1038/sj.bjc.6600079] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 4.9] [Reference Citation Analysis]
21 D'angelica MI, Shoup MC, Nissan A. Randomized Clinical Trials in Advanced and Metastatic Colorectal Carcinoma. Surgical Oncology Clinics of North America 2002;11:173-91. [DOI: 10.1016/s1055-3207(03)00080-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]